BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8864752)

  • 1. Intra- and extracellular immunization against HIV-1 infection with lymphocytes transduced with an AAV vector expressing a human anti-gp120 antibody.
    Chen JD; Yang Q; Yang AG; Marasco WA; Chen SY
    Hum Gene Ther; 1996 Aug; 7(13):1515-25. PubMed ID: 8864752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody.
    Chen SY; Khouri Y; Bagley J; Marasco WA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5932-6. PubMed ID: 8016092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
    Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
    J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120.
    Masiero S; Del Vecchio C; Gavioli R; Mattiuzzo G; Cusi MG; Micheli L; Gennari F; Siccardi A; Marasco WA; Palù G; Parolin C
    Gene Ther; 2005 Feb; 12(4):299-310. PubMed ID: 15496956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged expression of an anti-HIV-1 gp120 minibody to the female rhesus macaque lower genital tract by AAV gene transfer.
    Abdel-Motal UM; Harbison C; Han T; Pudney J; Anderson DJ; Zhu Q; Westmoreland S; Marasco WA
    Gene Ther; 2014 Sep; 21(9):802-10. PubMed ID: 24965083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.
    Wang HW; Cole D; Jiang WZ; Jin HT; Fu N; Chen ZL; Jin NY
    Clin Exp Immunol; 2005 Jul; 141(1):72-80. PubMed ID: 15958072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-phase approach for the expression of high-affinity human anti-human immunodeficiency virus immunoglobulin Fab domains in Escherichia coli.
    Takeda S; Dorfman NA; Robert-Guroff M; Notkins AL; Rando RF
    Hybridoma; 1995 Feb; 14(1):9-18. PubMed ID: 7768538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
    Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
    Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.
    Wang S; Pal R; Mascola JR; Chou TH; Mboudjeka I; Shen S; Liu Q; Whitney S; Keen T; Nair BC; Kalyanaraman VS; Markham P; Lu S
    Virology; 2006 Jun; 350(1):34-47. PubMed ID: 16616287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS.
    Morgan RA; Looney DJ; Muenchau DD; Wong-Staal F; Gallo RC; Anderson WF
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):183-91. PubMed ID: 2328156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates.
    Kessler JA; McKenna PM; Emini EA; Chan CP; Patel MD; Gupta SK; Mark GE; Barbas CF; Burton DR; Conley AJ
    AIDS Res Hum Retroviruses; 1997 May; 13(7):575-82. PubMed ID: 9135875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
    Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
    J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
    Duan L; Zhu M; Bagasra O; Pomerantz RJ
    Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
    Ahmad A; Ladha A; Cohen EA; Menezes J
    Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integration.
    Zhang C; Cortez NG; Berns KI
    Hum Gene Ther; 2007 Sep; 18(9):787-97. PubMed ID: 17760515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.
    Laube LS; Burrascano M; Dejesus CE; Howard BD; Johnson MA; Lee WT; Lynn AE; Peters G; Ronlov GS; Townsend KS
    Hum Gene Ther; 1994 Jul; 5(7):853-62. PubMed ID: 7981310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of anti-HIV-1 immune responses by retroviral vectors.
    Jolly DJ; Warner JF
    Biotechnol Ther; 1991; 2(1-2):179-93. PubMed ID: 1845120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.
    Kim M; Qiao ZS; Montefiori DC; Haynes BF; Reinherz EL; Liao HX
    AIDS Res Hum Retroviruses; 2005 Jan; 21(1):58-67. PubMed ID: 15665645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection.
    Schroers R; Davis CM; Wagner HJ; Chen SY
    Gene Ther; 2002 Jul; 9(13):889-97. PubMed ID: 12080383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.